Maheen Adamson, Ph.D.

adamson-maheen-phdMaheen Adamson, Ph.D.
Senior Scientific Research Director

Dr. Maheen Adamson is the senior scientific research director for the Defense and Veterans Brain Injury Center (DVBIC) at the VA Palo Alto Health Care System. She is employed by PAVIR and also a clinical associate professor of psychiatry and behavioral sciences at Stanford University. Adamson completed her undergraduate degrees in neurobiology and women studies at University of California, Irvine. She completed her Ph.D. in neuroscience from the University of Southern California and a postdoctoral fellowship in psychiatry and behavioral sciences at Stanford School of Medicine.

Adamson’s expertise and interests span employing translational neuroscience methodologies for diagnostic and therapeutic treatments in mild and moderate TBI, including structural and functional changes in the brain associated with Alzheimer’s disease and TBI, especially in the military population. She currently serves as PI or Co-I on several Department of Veterans Affairs and Department of Defense funded grants.

Adamson has authored numerous peer-reviewed publications on cognitive and neural basis of Alzheimer’s disease and TBI, has received recognition in national and international settings and is a frequent presenter at national and international conferences. She is also intricately involved in mentoring research fellows in the psychiatry department at Stanford and serves on the Board of Directors for Brain Injury Association of California. Her long-term goal is to integrate advanced treatment and diagnostics into standard-of-care provided to veterans and military personnel to improve their daily function and reintegration into society.

DVBIC is a part of the U.S. Military Health System. Specifically, DVBIC is the traumatic brain injury (TBI) operational component of the Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury (DCoE). Founded in 1992 by Congress, DVBIC’s responsibilities have grown as its network of care and treatment sites has grown. LEARN MORE >